224 related articles for article (PubMed ID: 9483232)
1. Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand.
Lloyd JV; Street AM; Berry E; McPherson J; Ekert H; Lammi A; McWhirter WR; Duncan EM; Maxwell EL; Rowell J; Baker RI; Leahy MF; Jupe D
Aust N Z J Med; 1997 Dec; 27(6):658-64. PubMed ID: 9483232
[TBL] [Abstract][Full Text] [Related]
2. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
Mannucci PM; Franchini M
Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study.
Fiks-Sigaud M; Bendelac L; Parquet A; Verroust F; Torchet MF; Berthier AM; Fressinaud E; Guerois C; Aillaud MF; Boneu B
Vox Sang; 1993; 64(4):210-4. PubMed ID: 8517049
[TBL] [Abstract][Full Text] [Related]
4. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Klukowska A; Zieleniewska B
Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
[TBL] [Abstract][Full Text] [Related]
5. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
7. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R
Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894
[TBL] [Abstract][Full Text] [Related]
8. Experience with highly purified porcine factor VIII in a patient with haemophilia A and a factor VIII inhibitor.
Colvin BT; Ainsworth M; Buckley C
Clin Lab Haematol; 1983; 5(1):55-9. PubMed ID: 6406130
[TBL] [Abstract][Full Text] [Related]
9. How I manage patients with inherited haemophilia A and B and factor inhibitors.
Ljung RCR
Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992
[TBL] [Abstract][Full Text] [Related]
10. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.
Gribble J; Garvey MB
Haemophilia; 2000 Sep; 6(5):482-5. PubMed ID: 11012689
[TBL] [Abstract][Full Text] [Related]
11. Variation in inhibitor reactivity in acquired haemophilia A with different concentrates.
Sukhu K; Keeling DM; Giangrande PL
Clin Lab Haematol; 2000 Oct; 22(5):287-90. PubMed ID: 11122270
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with haemophilia and inhibitory antibodies.
Giangrande PL
Indian J Pediatr; 2003 Aug; 70(8):655-9. PubMed ID: 14510087
[TBL] [Abstract][Full Text] [Related]
13. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
Koshihara K; Qian J; Lollar P; Hoyer LW
Blood; 1995 Sep; 86(6):2183-90. PubMed ID: 7662967
[TBL] [Abstract][Full Text] [Related]
14. The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIII.
Hultin MB; Hennessey J
Thromb Res; 1989 Jul; 55(1):51-6. PubMed ID: 2506662
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party.
Hay CR; Colvin BT; Ludlam CA; Hill FG; Preston FE
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):134-8. PubMed ID: 8735802
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
Reipert BM; van Helden PM; Schwarz HP; Hausl C
Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
18. Summary report of the First International Conference on inhibitors in haemophilia A.
Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F
Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354
[No Abstract] [Full Text] [Related]
19. Factor VIII inhibitors in mild and moderate-severity haemophilia A.
Hay CR
Haemophilia; 1998 Jul; 4(4):558-63. PubMed ID: 9873794
[TBL] [Abstract][Full Text] [Related]
20. [Acquired haemophilia due to autoantibodies against factor VIII].
von Depka Prondzinski M
Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
